The HealthSky Liquid-Based Cytology Machine is an advanced diagnostic tool designed to enhance the efficiency of cytological examinations. Utilizing state-of-the-art liquid-based technology, this machine ensures high-quality sample preparation by uniformly dispersing cells and removing obscuring materials such as blood and mucus. The result is a clearer, more reliable slide that facilitates the detection of cellular abnormalities, including precancerous and cancerous lesions. With its user-friendly interface, automated processing, and robust quality control features, the HealthSky Liquid-Based Cytology Machine streamlines laboratory workflows, reduces human error, and ultimately improves patient outcomes.
HealthSky Sieve Sedimentation Cytologic Technology (SCT) is a unique and patented cytology sample preparation technology developed by HealthSky. After the specimen is transferred to the chamber, obscuring factors such as blood and mucus are filtered out by the sieve, the inflammatory cells and other interferents are separated by density sedimentation, the relevant diagnostic cells are enriched on the slides which are specially treated. The prepared slides are featured with clean background, evenly distributed monolayer cells, and better cellular morphology.
An LBC machine is a medical device used to prepare samples for cytological examination. It processes cells collected from various body sites (e.g., cervix, lungs) and suspends them in a liquid medium, which is then used to create a thin, uniform layer of cells on a microscope slide for analysis.
Liquid-based cytology (LBC) is a versatile technique that can be used to process a variety of specimen types for cytological examination, include gynecological (gyn) and non-gynecological (non-gyn) specimen.
Processing a sample using a liquid-based cytology (LBC) machine typically takes about 30 minutes to an hour, depending on the specific system and workflow used.
Liquid-based cytology (LBC) offers several advantages over conventional cytology, including improved sample quality with cleaner and more evenly distributed cells, higher detection rates for abnormalities, and fewer unsatisfactory samples. It also allows for additional molecular testing, such as HPV, on the same sample, improves workflow efficiency with automated processing, and provides better cell preservation. These benefits lead to enhanced diagnostic accuracy and potential cost savings by reducing the need for repeat tests.
EN
